In the HER-2 ultra-low group, 123 (49.4%) cases were categorized as having T1 tumor size, 116 (46.6%) cases as T2, 8 (3.2%) cases as T3; and 2 (0.8%) cases as T4. This evidence concerns the gene ERBB2 and neoplasm.